Austria: Results from Best of Biotech

Article Abstract:

The Best of Biotech programme of the Austrian Innovation Agency has so far resulted in the creation of three biotech start-ups. Amynon of Pidder Jansen-Duerr in Innsbruck is working on agents that block the linking of viral proteins to the body's proteins. Fibrex of Peter Petzelbauer in Vienna is working on drugs to prevent sequelae of cardiac infarctions. Oridis of Kurt Zatloukal in Graz is working on DNA chips and other analysis methods for the development of tumour medicines. Another seven companies are in the phase of being started up. Most of the Best of Biotech projects involve medical biotechnology.

Cardiovascular Preparations, Cardiovascular agents, Fibrex Inc.

---

Austria: Biotech R&D for medicine

Article Abstract:

Nine of the ten projects participating in phase three of the Best of Biotech competition of the Austrian Innovation Agency are in the field of human medicine. Green Hills Biotechnology is carrying out research into cold and influenza treatments based on an organic molecule. Immunobiotech Tirol is working on treatments for kidney tumours on the basis of dendritic cells. SmartMeds, which emerged from a Boehringer-Ingelheim unit, aims to develop a vaccine against melanoma by 2007 and one against colon cancer by 2009.

Antiinfective Preparations, Vaccines & Antigens for Human Use, Biological Product (except Diagnostic) Manufacturing, Biological products exc. diagnostic, Anti-infective agents, Biological products

---

AUSTRIA: BOEHRINGER INGELHEIM IN R&D PROJECT

Article Abstract:

Sch 190mn is to be spent by the City of Vienna on the construction of a new biotechnology centre in Dr Bohr-Gasse in Vienna. Construction start is scheduled for September 2001. The building will accommodate a research project of the Austrian Academy of Sciences and Boehringer Ingelheim, dealing with molecular origins of diseases.

Manufacturing and Industrial Building Construction, Industrial Buildings, Industrial buildings and warehouses, Medical Research, Industrial construction, Boehringer Ingelheim Group

Similar abstracts:

• Abstracts: Australia commits to the helicopter. Flying Australia's Seahawk. In transition
• Abstracts: Australia's Ninox program pioneers new technologies. Russian mission system for maritime-partol aircraft. Turkish direction-finding system expands its reach
• Abstracts: AT and T turns tough with regulators. WorldCom agrees to settlement for 'slamming.' So long to long distance
• Abstracts: Skies look clear for EVA. Battle for Australia's skies takes a new twist. Observers see Qantas taking wing despite turbulence
• Abstracts: Textron will buy David Brown Group for $326.6 million. Bank of Scotland may sell Australian stake to St. George

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.